Sep 4, 2021 07:20AM salamandra wrote:
I totally support the wish for better drugs with fewer side effects, with more personalized prescribing technology (like oncotype).
I totally support any woman who makes an informed decision for herself that the side effects of the drug are not worth the potential benefit. I support that whether she is making the decision after having tried every possible variation of hormonal treatment and experienced bad side effects, or whether she has tried none of them and is making a decision based on risks alone.
I personally came very close to rejecting hormonal treatment after only trying solid tamoxifen, and I lay some of the blame for that on the way it was presented/handled by my doctor - so I also will not blindly defend the medical establishment's role here. (Details are spread across the boards so I won't go into the whole story again, but the short version is that I found a way forward with her that I am really happy with).
There is absolutely room for improvement in how oncologists support women in this process, starting with acknowledgement that hormone therapy can be as impactful on quality of life as chemotherapy, if not more so. I was incredibly glad when I saw a study shared here I think last year that addressed that question, and I hope there will be more studies and more education for physicians.
But I have a big problem with mischaracterizing science, mischaracterizing statistics, confusing evidence with anecdotes, and anything that makes it more difficult for a person to get to that place of a well informed decision.
When a woman comes to these boards and asks for input, I will give my input that I think it's probably worth trying these drugs for any woman who anticipates/strongly desires more than 5-10 years more of life, that plenty of women do find a variation of these drugs that are either basically side-effect-free or very tolerable, and that in most cases it will be worth an experimentation process to look for one that works for her.
FWIW, this thread is "rejecting hormone therapy', which I understood to extend both to AIs and to SERMs, and SERMs most definitely are not estrogen deprivation therapy. Some levels/types of estrogen actually increase. The term hormone therapy or endocrine therapy is meant to encompass both of these primary modes. If you want to call it treatment instead of therapy, it seems semantic to me and I wonder if you are consistent and call it chemotreatment instead of chemotherapy, but it doesn't really matter. Referring to it broadly as estrogen deprivation though is a misguiding mischaracterization that contributes to misinformation and seems like part of the problem rather than the solution.